CSIMarket
 


Avid Bioservices Inc   (CDMO)
Other Ticker:  
 
 

CDMO's Income from Cont. Operations Growth by Quarter and Year

Avid Bioservices Inc 's Income from Cont. Operations results by quarter and year




CDMO Income from Cont. Operations (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter April - -0.31 115.60 1.99
III Quarter January - 0.46 2.25 2.21
II Quarter October -9.51 -1.16 3.52 2.28
I Quarter July -2.09 1.56 6.30 4.73
FY   -11.60 0.55 127.67 11.21



CDMO Income from Cont. Operations second quarter 2024 Y/Y Growth Comment
Avid Bioservices Inc in the second quarter 2024 recorded loss from continued operations of $ -9.51 millions.

Looking into second quarter 2024 results within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Income from Cont. Operations growth. While Avid Bioservices Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. 1083 in the second quarter 2024.




CDMO Income from Cont. Operations ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter April - - 5709.05 % -
III Quarter January - -79.56 % 1.81 % -
II Quarter October - - 54.39 % -
I Quarter July - -75.24 % 33.19 % -
FY   - -99.57 % 1038.89 % -

Financial Statements
Avid Bioservices Inc 's second quarter 2024 Income from Cont. Operations $ -9.51 millions CDMO's Income Statement
Avid Bioservices Inc 's second quarter 2023 Income from Cont. Operations $ -1.16 millions Quarterly CDMO's Income Statement
New: More CDMO's historic Income from Cont. Operations Growth >>


CDMO Income from Cont. Operations (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter April - - 5037.78 % -9.95 %
III Quarter January - - -36.08 % -3.07 %
II Quarter October - - -44.13 % -51.8 %
I Quarter July - -98.65 % 216.58 % -
FY (Year on Year)   - -99.57 % 1038.89 % -




Income from Cont. Operations second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #75
Overall #1083

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
9776.06 % 1450.18 % -109.68 %
(Oct 31 2021)   (Oct 31 2023)
Income from Cont. Operations second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #75
Overall #1083
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
9776.06 % 1450.18 % -109.68 %
(Oct 31 2021)   (Oct 31 2023)

Income from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Avid Bioservices Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDMO's II. Quarter Q/Q Income from Cont. Operations Comment
Current loss from continued operations of -9.51 millions by Avid Bioservices Inc look even worse considering the loss from continued operations -2.09 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Avid Bioservices Inc achieved highest sequential Income from Cont. Operations growth. While Avid Bioservices Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDMO's II. Quarter Q/Q Income from Cont. Operations Comment
II. Quarter 2024 accomplishment of -9.51 millions by Avid Bioservices Inc come out even less good compare to the -2.09 millions a quarter before.

Within Major Pharmaceutical Preparations industry Avid Bioservices Inc achieved highest sequential Income from Cont. Operations growth. While Avid Bioservices Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Avid Bioservices Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Oct 31 2023)
12 Months Ending
(Jul 31 2023)
12 Months Ending
(Apr 30 2023)
12 Months Ending
(Jan 31 2023)
12 Months Ending
(Oct 31 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ -11.45 $ -3.10 $ 0.56 $ 116.47 $ 118.25
Y / Y Income from Cont. Operations Growth (TTM) - - -99.56 % 728.06 % 743.23 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 43 # 29 # 31 # 116 # 44
Seqeuential Income from Cont. Operations Change (TTM) - - -99.52 % -1.51 % -3.81 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1083 # 1153 # 41 # 939 # 1561




Cumulative Income from Cont. Operations growth Comment
Avid Bioservices Inc realized trailing twelve months loss from continued operations of $ -11 millions, in the Oct 31 2023, compare to Income from Cont. Operations of $ 118 millions a year ago.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 29 to 43.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
9776.06 %
1450.18 %
-109.68 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 15
Healthcare Sector # 3
Overall # 43

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
9776.06 %
1450.18 %
-109.68 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 75
S&P 500 # 1083
Cumulative Income from Cont. Operations growth Comment
Avid Bioservices Inc realized trailing twelve months loss from continued operations of $ -11 millions, in the Oct 31 2023, compare to Income from Cont. Operations of $ 118 millions a year ago.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 29 to 43.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
9776.06 %
1450.18 %
-109.68 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 15
Healthcare Sector # 3
Overall # 43

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
9776.06 %
1450.18 %
-109.68 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 75
S&P 500 # 1083




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
CDMO's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for CDMO's Competitors
Income from Cont. Operations Growth for Avid Bioservices Inc 's Suppliers
Income from Cont. Operations Growth for CDMO's Customers

You may also want to know
CDMO's Annual Growth Rates CDMO's Profitability Ratios CDMO's Asset Turnover Ratio CDMO's Dividend Growth
CDMO's Roe CDMO's Valuation Ratios CDMO's Financial Strength Ratios CDMO's Dividend Payout Ratio
CDMO's Roa CDMO's Inventory Turnover Ratio CDMO's Growth Rates CDMO's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Oct 31 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Oct 31 2023




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com